Skip to main content

Table 1 Origin and reference of bacterial strains used in the present study

From: Bacterial membrane activity of α-peptide/β-peptoid chimeras: Influence of amino acid composition and chain length on the activity against different bacterial strains

 

Origin

Ref

S. aureus 8325-4

Wildtype

[59]

K. pneumoniae ATCC 13883

Human, clinical

-

S. marcescens ATCC 8100

Human, clinical

-

E. coli ATCC 25922

Wildtype

-

E. coli MG1655

K-12 F- lambda-

[60]

E. coli AAS-EC-009

Human, clinical

a

E.coli AAS-EC-010

Human, clinical

a

L. monocytogenes 4446

Human, clinical

[61]

L. monocytogenes N53-1

Food processing

[62]

L. monocytogenes EGD

Wildtype

b

V. vulnificus ATCCT

Human, clinical

-

V. parahaemolyticus ATCCT

Human, clinical

-

  1. Susceptibility testing were carried out with a selection of twelve different bacterial strains comprising common laboratory strains and clinical strains derived from food-borne pathogens as well as pathogens responsible for nosocomial infections. a ESBL-producing clinical samples from Danish patients in 2007; b This strain was kindly provided by Werner Goebel, University of Würzburg.